HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun. 22, 2017--
Taro Pharmaceutical Industries Ltd. (NYSE:TARO, “Taro”) announced that
its Annual Report on Form 20-F for the fiscal year ended March 31, 2017,
filed with the Securities and Exchange Commission (the “SEC”), is
available within the Investor Relations section of Taro’s website at www.taro.com.
Hard copies of the report may be ordered free of charge by sending
Taro Pharmaceuticals U.S.A., Inc.
Three Skyline Drive
attention: William J. Coote or
via email to William.Coote@Taro.com
Additionally, the report may be accessed on the SEC’s website at www.sec.gov.
Taro Pharmaceutical Industries Ltd. is a multinational, science-based
pharmaceutical company, dedicated to meeting the needs of its customers
through the discovery, development, manufacturing and marketing of the
highest quality healthcare products. For further information on Taro
Pharmaceutical Industries Ltd., please visit Taro’s website at www.taro.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170622005182/en/
Source: Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer,
J. Coote, 914-345-9001
AVP, Business Finance, Treasurer
and Investor Relations